Aderonke Adeyemi
Family · Washington, DCNPI 1407480783
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 141 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,697, more than ten times the $142 reported in 2021. Among family clinicians in DC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 141 payments — averaging $25.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$854
- AstraZeneca$679
- Corcept Therapeutics$326
- Novo Nordisk$276
- Esperion Therapeutics, Inc.$233
- E.r. Squibb & Sons, L.L.C.$148
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,571100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 38 | $854 |
| AstraZeneca | 14 | $679 |
| Corcept Therapeutics | 10 | $326 |
| Novo Nordisk | 10 | $276 |
| Esperion Therapeutics, Inc. | 10 | $233 |
| E.r. Squibb & Sons, L.L.C. | 6 | $148 |
| Verona Pharma, Inc. | 6 | $117 |
| Pfizer | 6 | $117 |
| Amgen | 5 | $116 |
| Lilly USA, LLC | 6 | $112 |
| Bayer | 5 | $83 |
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| Sumitomo Pharma America, Inc. | 3 | $75 |
| Boehringer Ingelheim | 3 | $53 |
| Exact Sciences | 2 | $53 |
| Teva Pharmaceuticals USA, Inc. | 3 | $49 |
| Harmony Biosciences LLC | 1 | $37 |
| Astellas Pharma US Inc | 2 | $35 |
| Almatica Pharma LLC | 1 | $27 |
| Linus Health, Inc. | 1 | $21 |
| Shield Therapeutics Inc | 1 | $21 |
| Neurocrine Biosciences, Inc. | 1 | $18 |
| Phadia US Inc. | 1 | $16 |
| Merck | 1 | $15 |
| Seqirus USA Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,571 in reported general payments places this provider in the 90th percentile of 392 family providers in District of Columbia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 14 | $19,073 |
| EliquisApixaban | 20 | $18,984 |
| FarxigaDapagliflozin Propanediol | 15 | $15,368 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $13,014 |
| Tresiba Flextouch U-100Insulin Degludec | 11 | $10,691 |
| Rosuvastatin Calcium | 29 | $830 |
| Bupropion XlBupropion Hcl | 12 | $778 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 24 | $758 |
| Atorvastatin Calcium | 77 | $734 |
| Metoprolol Succinate | 31 | $623 |
| Pantoprazole Sodium | 29 | $613 |
| Levothyroxine Sodium | 41 | $571 |
| Oxybutynin Chloride ErOxybutynin Chloride | 16 | $540 |
| Amlodipine Besylate | 82 | $514 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 33 | $452 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $112 | $19,07314 claims |
| PfizerEliquis | $117 | $18,98420 claims |
| AstraZenecaFarxiga | $679 | $15,36815 claims |
| Almatica Pharma LLCSertraline Hcl | $27 | $8913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 392 family providers in District of Columbia.
Other family in Washington
- Amy StewartWashington$489K
- Kara CouchWashington$144K
- Laura XandersWashington$109K
- Laura MackeWashington$39K
- Cassandra ThompsonWashington$11K
- Sharmin DiazWashington$9K
- Emily BertrandWashington$8K
- Ana Carrion-GelabertWashington$7K
- Chanda CopelandWashington$7K
- Suad NsouliWashington$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.